Skip to main content
. 2023 Jul 18;12(14):14881–14891. doi: 10.1002/cam4.5843

FIGURE 2.

FIGURE 2

Survival curves of overall survival (OS) between extensive stage small‐cell lung cancer (ES‐SCLC) patients who chose immunotherapy combined with chemotherapy and chemotherapy as the first‐line (FL) treatment.